Provided by Tiger Trade Technology Pte. Ltd.

Repligen

181.13
+0.84000.47%
Volume:1.10M
Turnover:198.19M
Market Cap:10.20B
PE:248.12
High:182.43
Open:179.66
Low:175.75
Close:180.29
52wk High:188.73
52wk Low:100.99
Shares:56.29M
Float Shares:53.32M
Volume Ratio:1.05
T/O Rate:2.06%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.7300
EPS(LYR):0.8600
ROE:1.99%
ROA:1.40%
PB:4.83
PE(LYR):210.62

Loading ...

Repligen price target lowered to $140 from $170 at Evercore ISI

TIPRANKS
·
Apr 06

Reassessing Repligen (RGEN) Valuation After Recent Share Price Rebound And Bioprocessing Growth Expectations

Simply Wall St.
·
Apr 05

Repligen publishes 2025 annual report, posts $738 million revenue in 2025

Reuters
·
Apr 03

Repligen announces annual shareholder meeting notice and proxy statement

Reuters
·
Apr 03

Q/C Technologies delays annual report filing, seeks 15-day extension

Reuters
·
Apr 01

Is Repligen (RGEN) Pricing Look Attractive After Steep Multi Year Share Price Declines

Simply Wall St.
·
Apr 01

Repligen Is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
Mar 23

Repligen: Strong Execution, Innovation, and Cross‑Selling Momentum Support Sustained Growth and Reaffirmed Buy Rating

TIPRANKS
·
Mar 23

Repligen price target raised to $208 from $180 at H.C. Wainwright

TIPRANKS
·
Mar 23

Q/C Technologies dismisses Stephano Slack as auditor and hires Grassi & Co

Reuters
·
Mar 14

Repligen to Present at Leerink, Barclays, and KeyBanc Healthcare Investor Conferences

Reuters
·
Mar 05

Repligen Corporation to Present at Upcoming March Conferences

GlobeNewswire
·
Mar 05

Analysts Have Conflicting Sentiments on These Healthcare Companies: Amarin (AMRN), Ionis Pharmaceuticals (IONS) and Repligen (RGEN)

TIPRANKS
·
Feb 26

Stifel Nicolaus Sticks to Its Buy Rating for Repligen (RGEN)

TIPRANKS
·
Feb 25

Repligen Is Maintained at Overweight by Wells Fargo

Dow Jones
·
Feb 25

UBS Adjusts Price Target on Repligen to $195 From $200, Maintains Buy Rating

MT Newswires Live
·
Feb 25

Repligen Is Maintained at Outperform by Evercore ISI Group

Dow Jones
·
Feb 25

Repligen price target lowered to $170 from $180 at Evercore ISI

TIPRANKS
·
Feb 25

Repligen (RGEN) Gets a Hold from Guggenheim

TIPRANKS
·
Feb 25

Repligen price target lowered to $180 from $190 at Wells Fargo

TIPRANKS
·
Feb 25